Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Tobacco, illicit drugs use and risk of cardiovascular disease in patients living with HIV.

Raposeiras-Roubín S, Abu-Assi E, Iñiguez-Romo A.

Curr Opin HIV AIDS. 2017 Aug 10. doi: 10.1097/COH.0000000000000407. [Epub ahead of print]

PMID:
28799996
2.

Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.

Puri R, Otaegui I, Sabaté M, Serra-Peñaranda A, Puigfel M, Perez de Prado A, Nombela-Franco L, de la Torre Hernandez JM, Ortas Nadal R, Iniguez-Romo A, Jiménez G, Fernandez-Vazquez F, Cuellas-Ramon C, Gonzalo N, Alfonso Jiménez Diaz V, Duocastella L, Molina M, Amoros M, Perez I, Barria Perez A, Pelletier Beaumont E, Nicholls SJ, Garcia Del Blanco B, Rodés-Cabau J.

Catheter Cardiovasc Interv. 2017 Jul 14. doi: 10.1002/ccd.27189. [Epub ahead of print]

PMID:
28707379
3.

The RECALCAR Project. Healthcare in the Cardiology Units of the Spanish National Health System, 2011 to 2014.

Íñiguez Romo A, Bertomeu Martínez V, Rodríguez Padial L, Anguita Sánchez M, Ruiz Mateas F, Hidalgo Urbano R, Bernal Sobrino JL, Fernández Pérez C, Macaya de Miguel C, Elola Somoza FJ.

Rev Esp Cardiol (Engl Ed). 2017 Jul;70(7):567-575. doi: 10.1016/j.rec.2017.03.022. Epub 2017 Apr 28. English, Spanish.

PMID:
28457812
4.

Not All That Blurs is Clot: An Unusual But Not Infrequent Cause of Acute Coronary Syndrome.

Hernández Hernández E, Jiménez Díaz VA, Baz Alonso JA, Fernández Barbeira S, Vitela Rodríguez JA, Andrade Pacheco J, Ortiz Sáez A, Bastos Fernández G, De Miguel Castro AA, Iñiguez Romo A.

J Invasive Cardiol. 2017 Apr;29(4):E53-E54.

5.

Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations.

López-Fernández T, Martín García A, Santaballa Beltrán A, Montero Luis Á, García Sanz R, Mazón Ramos P, Velasco Del Castillo S, López de Sá Areses E, Barreiro-Pérez M, Hinojar Baydes R, Pérez de Isla L, Valbuena López SC, Dalmau González-Gallarza R, Calvo-Iglesias F, González Ferrer JJ, Castro Fernández A, González-Caballero E, Mitroi C, Arenas M, Virizuela Echaburu JA, Marco Vera P, Íñiguez Romo A, Zamorano JL, Plana Gómez JC, López Sendón Henchel JL.

Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):474-486. doi: 10.1016/j.rec.2016.12.041. Epub 2017 Mar 18. English, Spanish.

PMID:
28330818
6.

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR; FOURIER Steering Committee and Investigators.

N Engl J Med. 2017 May 4;376(18):1713-1722. doi: 10.1056/NEJMoa1615664. Epub 2017 Mar 17.

PMID:
28304224
7.

Risk Scores From PARIS Registry: Are They Useful in a Contemporary Cohort of ACS Patients?

Raposeiras-Roubín S, Abu-Assi E, Rioboó-Lestón L, Míguez JO, Paz RC, Caneiro Queija B, Calvo Iglesias F, Iñiguez-Romo A.

J Am Coll Cardiol. 2016 Nov 29;68(21):2391-2392. doi: 10.1016/j.jacc.2016.05.104. No abstract available.

PMID:
27884261
8.

Classification and Quality Standards of Heart Failure Units: Scientific Consensus of the Spanish Society of Cardiology.

Anguita Sánchez M, Lambert Rodríguez JL, Bover Freire R, Comín Colet J, Crespo Leiro MG, González Vílchez F, Manito Lorite N, Segovia Cubero J, Ruiz Mateas F, Elola Somoza FJ, Íñiguez Romo A.

Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):940-950. doi: 10.1016/j.rec.2016.06.006. Epub 2016 Aug 27. English, Spanish.

PMID:
27576081
9.

NT-proBNP for risk stratification of nonagenarian patients with severe symptomatic aortic stenosis.

Raposeiras-Roubín S, Abu-Assi E, López-Rodríguez E, Agra-Bermejo R, Pereira-López EM, Calvo-Iglesias F, Íñiguez-Romo A.

Int J Cardiol. 2016 Nov 15;223:785-786. doi: 10.1016/j.ijcard.2016.08.195. Epub 2016 Aug 10. No abstract available.

PMID:
27573609
10.

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.

Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators.

Br J Haematol. 2016 Aug;174(4):610-23. doi: 10.1111/bjh.14084. Epub 2016 Apr 12.

PMID:
27071942
11.

Pulmonary vein stenosis: Etiology, diagnosis and management.

Pazos-López P, García-Rodríguez C, Guitián-González A, Paredes-Galán E, Álvarez-Moure MÁ, Rodríguez-Álvarez M, Baz-Alonso JA, Teijeira-Fernández E, Calvo-Iglesias FE, Íñiguez-Romo A.

World J Cardiol. 2016 Jan 26;8(1):81-8. doi: 10.4330/wjc.v8.i1.81. Review.

12.

Cost-Effectiveness of A Left Atrial Appendage Closure Device In Patients With Non-Valvular Atrial Fibrillation Unable or Unwilling to Tolerate Oral Anticoagulant Therapy In Italy And Spain.

Amin A, Cruz González I, Reddy V, Holmes D, Berti S, Iñiguez Romo A, De Deppo L, Priest V, Simmonds M, Lee C, Wasserman M, Margonato A.

Value Health. 2015 Nov;18(7):A357. doi: 10.1016/j.jval.2015.09.677. Epub 2015 Oct 20. No abstract available.

13.

Interhospital Variability in Drug Prescription After Acute Coronary Syndrome: Insights From the ACDC Study.

Ferreira-González I, Carrillo X, Martín V, de la Torre Hernández JM, Baz JA, Navarro Manchón J, Masotti M, Cequier Á, Cárdenas M, Alfonso Manterola F; ACDC research group.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):117-24. doi: 10.1016/j.rec.2015.04.018. Epub 2015 Aug 5.

PMID:
26253861
14.

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.

Lip GY, Rushton-Smith SK, Goldhaber SZ, Fitzmaurice DA, Mantovani LG, Goto S, Haas S, Bassand JP, Camm AJ, Ambrosio G, Janský P, Al Mahmeed W, Oh S, van Eickels M, Raatikainen P, Steffel J, Oto A, Kayani G, Accetta G, Kakkar AK; GARFIELD-AF Investigators.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S12-20. doi: 10.1161/CIRCOUTCOMES.114.001556. Epub 2015 Feb 24.

15.

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

O'Donoghue ML, Braunwald E, White HD, Lukas MA, Tarka E, Steg PG, Hochman JS, Bode C, Maggioni AP, Im K, Shannon JB, Davies RY, Murphy SA, Crugnale SE, Wiviott SD, Bonaca MP, Watson DF, Weaver WD, Serruys PW, Cannon CP; SOLID-TIMI 52 Investigators, Steen DL.

JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061. Erratum in: JAMA. 2014 Oct 8;312(14):1473. Dylan P. Steen[corrected to Dylan L. Steen].

16.

Post-introduction observation of transcatheter aortic valve implantation in Galicia (Spain).

Varela-Lema L, Queiro-Verdes T, Baz-Alonso JA, Cuenca-Castillo JJ, Durán-Muñoz D, Gónzalez-Juanatey JR, Herrera Noreña JM, Iñiguez-Romo A, López-Otero D, Pradas-Montilla G, Rubio-Álvarez J, Salgado-Fernández J, Trillo Nouche R, Vázquez-González N, López-García M.

J Eval Clin Pract. 2015 Feb;21(1):34-42. doi: 10.1111/jep.12225. Epub 2014 Jul 15.

PMID:
25040767
17.

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial.

Saito S, Valdes-Chavarri M, Richardt G, Moreno R, Iniguez Romo A, Barbato E, Carrie D, Ando K, Merkely B, Kornowski R, Eltchaninoff H, James S, Wijns W; CENTURY II Investigators.

Eur Heart J. 2014 Aug 7;35(30):2021-31. doi: 10.1093/eurheartj/ehu210. Epub 2014 May 19.

18.

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.

Camenzind E, Boersma E, Wijns W, Mauri L, Rademaker-Havinga T, Ordoubadi FF, Suttorp MJ, Al Kurdi M, Steg PG; PROTECT Steering Committee and Investigators.

Eur Heart J. 2014 Aug 1;35(29):1932-48. doi: 10.1093/eurheartj/ehu084. Epub 2014 Mar 13.

PMID:
24627416
19.

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.

Camenzind E, Wijns W, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Boersma E, Vranckx P, McFadden E, Serruys PW, O'Neil WW, Jorissen B, Van Leeuwen F, Steg PG; PROTECT Steering Committee and Investigators.

Lancet. 2012 Oct 20;380(9851):1396-405. doi: 10.1016/S0140-6736(12)61336-1. Epub 2012 Aug 27.

PMID:
22951082
20.

[Prognostic impact of interventional approach in non-ST segment elevation acute coronary syndrome in very elderly patients].

Villanueva-Benito I, Solla-Ruíz I, Paredes-Galán E, Díaz-Castro O, Calvo-Iglesias FE, Baz-Alonso JA, Iñiguez-Romo A.

Rev Esp Cardiol. 2011 Oct;64(10):853-61. doi: 10.1016/j.recesp.2011.04.022. Epub 2011 Jul 23. Spanish.

Supplemental Content

Loading ...
Support Center